Schonfeld Strategic Advisors LLC Delcath Systems, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.2 - $11.72 $587,520 - $956,352	-81,600 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$8.44 - $12.65 $43,888 - $65,780	-5,200 Reduced 5.99%	81,600 $851,000
Q2 2021 Aug 16, 2021	SELL	$9.54 - $15.1 $214,029 - $338,768	-22,435 Reduced 20.54%	86,800 $1.1 Million
Q1 2021 May 17, 2021	BUY	$12.42 - $23.81 $1.36 Million - $2.6 Million	109,235 New	109,235 $1.36 Million

7.93M

118K

69.9K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $89.1M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.